🇺🇸 FDA
Patent

US 10815219

2,4-diaminoquinazoline derivatives for inhibiting endoplasmic reticulum (ER) stress

granted A61KA61K47/51A61P

Quick answer

US patent 10815219 (2,4-diaminoquinazoline derivatives for inhibiting endoplasmic reticulum (ER) stress) held by The Board of Regents of the University of Oklahoma expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K47/51, A61P, A61P39/00